Prio Wealth Limited Partnership’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$61.5M Sell
541,979
-38,489
-7% -$4.57M 1.8% 12
2024
Q2
$71.9M Sell
580,468
-10,692
-2% -$1.38M 2.14% 11
2024
Q1
$78M Buy
591,160
+8,170
+1% +$1.01M 2.25% 10
2023
Q4
$63.6M Buy
582,990
+6,321
+1% +$656K 2.18% 11
2023
Q3
$59.4M Sell
576,669
-11,136
-2% -$1.2M 2.28% 10
2023
Q2
$67.8M Sell
587,805
-14,251
-2% -$1.62M 2.43% 8
2023
Q1
$64.1M Sell
602,056
-38,675
-6% -$4.18M 2.45% 7
2022
Q4
$71.1M Sell
640,731
-39,070
-6% -$3.99M 2.85% 6
2022
Q3
$58.5M Sell
679,801
-5,394
-0.8% -$482K 2.51% 9
2022
Q2
$62.5M Sell
685,195
-6,147
-0.9% -$545K 2.5% 7
2022
Q1
$56.7M Buy
691,342
+12,123
+2% +$956K 1.87% 12
2021
Q4
$52.1M Buy
679,219
+11,476
+2% +$914K 1.6% 18
2021
Q3
$50.2M Buy
667,743
+20,855
+3% +$1.59M 1.69% 17
2021
Q2
$50.3M Sell
646,888
-33,299
-5% -$2.48M 1.7% 17
2021
Q1
$50M Buy
680,187
+26,072
+4% +$1.92M 1.8% 19
2020
Q4
$51.1M Buy
654,115
+19,390
+3% +$1.48M 1.92% 14
2020
Q3
$50.2M Buy
634,725
+9,673
+2% +$758K 2.09% 12
2020
Q2
$46.1M Buy
625,052
+48,651
+8% +$3.66M 2.13% 11
2020
Q1
$42.3M Buy
576,401
+3,799
+0.7% +$299K 2.33% 11
2019
Q4
$49.7M Buy
572,602
+5,167
+0.9% +$424K 2.11% 11
2019
Q3
$45.6M Sell
567,435
-1,604
-0.3% -$129K 2.09% 12
2019
Q2
$45.5M Sell
569,039
-17,618
-3% -$1.35M 2.09% 12
2019
Q1
$46.6M Sell
586,657
-7,720
-1% -$577K 2.18% 9
2018
Q4
$43.3M Buy
594,377
+3,173
+0.5% +$224K 2.31% 9
2018
Q3
$40M Buy
591,204
+27,539
+5% +$1.75M 1.82% 18
2018
Q2
$32.6M Sell
563,665
-9,971
-2% -$563K 1.61% 20
2018
Q1
$29.8M Buy
573,636
+178,821
+45% +$9.66M 1.49% 23
2017
Q4
$21.2M Buy
394,815
+995
+0.3% +$55.2K 0.99% 32
2017
Q3
$24.1M Buy
393,820
+306,051
+349% +$18.6M 1.18% 30
2017
Q2
$5.37M Buy
87,769
+4,334
+5% +$264K 0.27% 81
2017
Q1
$5.06M Sell
83,435
-208
-0.2% -$12.6K 0.26% 79
2016
Q4
$4.7M Sell
83,643
-11,378
-12% -$666K 0.25% 80
2016
Q3
$5.66M Sell
95,021
-139
-0.1% -$8.13K 0.3% 74
2016
Q2
$5.23M Sell
95,160
-1,128
-1% -$60K 0.29% 77
2016
Q1
$4.86M Sell
96,288
-556
-0.6% -$27.2K 0.27% 79
2015
Q4
$4.88M Buy
96,844
+4,145
+4% +$209K 0.27% 80
2015
Q3
$4.37M Sell
92,699
-942
-1% -$50K 0.25% 82
2015
Q2
$5.09M Sell
93,641
-12,293
-12% -$689K 0.26% 82
2015
Q1
$5.81M Buy
105,934
+808
+0.8% +$45.8K 0.29% 79
2014
Q4
$5.7M Sell
105,126
-123
-0.1% -$6.85K 0.28% 82
2014
Q3
$5.95M Buy
105,249
+273
+0.3% +$15.3K 0.31% 83
2014
Q2
$5.79M Sell
104,976
-2,360
-2% -$129K 0.29% 84
2014
Q1
$5.81M Sell
107,336
-4,620
-4% -$239K 0.3% 85
2013
Q4
$5.35M Sell
111,956
-4,392
-4% -$201K 0.27% 90
2013
Q3
$5.29M Buy
116,348
+7,642
+7% +$349K 0.3% 89
2013
Q2
$4.82M Buy
+108,706
New +$4.86M 0.29% 91

Other funds holding MRK

Prio Wealth Limited Partnership's MRK Position: Q3 2024 in Review

Prio Wealth Limited Partnership reduced its Merck (MRK) stake by 6.6% in Q3 2024, selling an estimated $4.57M and leaving 541,979 shares worth $61.5M. The position accounts for 1.8% of the portfolio, ranked #12.

Prio Wealth Limited Partnership first reported a position in MRK in Q2 2013 and has held it in 46 quarters since. The position peaked at $78M in Q1 2024. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Prio Wealth Limited Partnership held 541,979 shares of Merck worth $61.5M as of Q3 2024.
  • Prio Wealth Limited Partnership sold 38,489 Merck shares in Q3 2024, an estimated $4.57M.
  • Merck made up 1.8% of Prio Wealth Limited Partnership's portfolio in Q3 2024, its #12 holding.
  • Prio Wealth Limited Partnership first reported a position in Merck in Q2 2013 and has held it in 46 quarters since.
  • Prio Wealth Limited Partnership's Merck position peaked at $78M in Q1 2024.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Prio Wealth Limited Partnership's 13F filing for Q3 2024, filed 21 Oct 2024.